Valuation : NEW RAYNPV

Market Cap 43.53M 5.55M 4.77M 4.5M 4.1M 7.67M 531M 7.74M 53.65M 20.65M 269M 20.85M 20.39M 855M P/E 2024
-2.43x
P/E 2025 -2.3x
Enterprise Value 8.58M 1.09M 941K 888K 809K 1.51M 105M 1.53M 10.57M 4.07M 53.05M 4.11M 4.02M 168M EV / Sales 2024
0.15x
EV / Sales 2025 0.16x
Free-Float
64.72%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 48 2020-07-30
Corporate Secretary - 2023-07-10
Director TitleAgeSince
Director/Board Member 76 2013-09-25
Director/Board Member 50 2017-06-19
Chairman 48 2021-05-14
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+2.38% - - 5.58M
-1.76%-3.78%-49.32%-16.23% 14.34B
-1.08%-5.18%-21.97%-13.84% 6.48B
-1.48%-1.15%-57.85%-32.62% 6.29B
-0.61%-0.96%-11.62%-20.83% 4.12B
-1.35%-0.05%-19.53%-38.41% 3.22B
-1.81%-3.03%+3.76%-28.77% 3.1B
+1.91%-4.42%-46.29%-27.17% 2.78B
+1.01%+9.22%+51.24% - 2.75B
-0.66%+3.95%-15.97%-6.29% 2.55B
Average -0.58%-0.21%-18.62%-23.02% 5.07B
Weighted average by Cap. -1.03%-1.51%-29.39%-21.40%

Financials

2024 2025
Net sales 93.94M 11.98M 10.3M 9.72M 8.86M 16.56M 1.15B 16.71M 116M 44.56M 581M 44.99M 44.01M 1.85B 130M 16.63M 14.3M 13.49M 12.29M 22.98M 1.59B 23.18M 161M 61.84M 806M 62.44M 61.07M 2.56B
Net income -31.01M -3.96M -3.4M -3.21M -2.92M -5.47M -378M -5.52M -38.22M -14.71M -192M -14.85M -14.53M -609M -20.07M -2.56M -2.2M -2.08M -1.89M -3.54M -245M -3.57M -24.73M -9.52M -124M -9.61M -9.4M -394M
Net Debt -60.71M -7.74M -6.66M -6.28M -5.72M -10.7M -740M -10.8M -74.82M -28.79M -375M -29.07M -28.44M -1.19B -34.96M -4.46M -3.83M -3.62M -3.3M -6.16M -426M -6.22M -43.08M -16.58M -216M -16.74M -16.37M -687M
Logo NEW RAYNPV
New Ray Medicine International Holding Ltd is an investment holding company principally engaged in the distribution and trading of pharmaceutical and the provision of marketing and promotion services. The Company operates its businesses through two segments. The Distribution and Trading of Pharmaceutical and Related Products segment is mainly engaged in the distribution and trading of drugs and chemical reagents for pharmaceutical. The Provision of Marketing and Promotion Services segment is mainly engaged in the provision of marketing and promotion services of drugs and chemical reagents for pharmaceutical. The Company mainly operates its businesses in the domestic market.
Employees
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!